# Tandy Leather Factory Inc: financial statements, quarterly

TLF · Nasdaq · CIK 909724 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tlf.md) · [Financials](/companies/tlf/financials.md) · [Filings](/companies/tlf/filings.md) · [Insiders](/companies/tlf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tlf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.5](/filings/0001140361-24-046229.md) | [20.8 d](/filings/0001140361-25-006103.md) | [19.3](/filings/0001140361-25-018382.md) | [17.3](/filings/0001140361-25-030265.md) | [17.4](/filings/0001140361-25-041386.md) | [20.5 d](/filings/0001140361-26-006550.md) | [19.0](/filings/0001140361-26-020544.md) | [17.8](/filings/0001140361-26-032236.md) | [17.3](/filings/0001140361-25-041386.md) | [22.3 d](/filings/0001140361-26-006550.md) | [19.7](/filings/0001140361-26-020544.md) | [18.0](/filings/0001140361-26-032236.md) |
| Cost of revenue | $m | [6.6](/filings/0001140361-24-046229.md) | [9.4 d](/filings/0001140361-25-006103.md) | [8.4](/filings/0001140361-25-018382.md) | [7.3](/filings/0001140361-25-030265.md) | [7.3](/filings/0001140361-25-041386.md) | [9.6 d](/filings/0001140361-26-006550.md) | [8.3](/filings/0001140361-26-020544.md) | [7.2](/filings/0001140361-26-032236.md) | [7.1](/filings/0001140361-25-041386.md) | [10.2 d](/filings/0001140361-26-006550.md) | [7.7](/filings/0001140361-26-020544.md) | [6.3](/filings/0001140361-26-032236.md) |
| Gross profit | $m | [10.9](/filings/0001140361-24-046229.md) | [11.5 d](/filings/0001140361-25-006103.md) | [10.9](/filings/0001140361-25-018382.md) | [10.0](/filings/0001140361-25-030265.md) | [10.0](/filings/0001140361-25-041386.md) | [10.8 d](/filings/0001140361-26-006550.md) | [10.7](/filings/0001140361-26-020544.md) | [10.6](/filings/0001140361-26-032236.md) | [10.2](/filings/0001140361-25-041386.md) | [12.1 d](/filings/0001140361-26-006550.md) | [12.0](/filings/0001140361-26-020544.md) | [11.7](/filings/0001140361-26-032236.md) |
| Operating income | $m | [0.9](/filings/0001140361-24-046229.md) | [1.8 d](/filings/0001140361-25-006103.md) | [0.6](/filings/0001140361-25-018382.md) | [0.1](/filings/0001140361-25-030265.md) | [(0.3)](/filings/0001140361-25-041386.md) | [0.2 d](/filings/0001140361-26-006550.md) | [0.3](/filings/0001140361-26-020544.md) | [0.1](/filings/0001140361-26-032236.md) | [(0.7)](/filings/0001140361-25-041386.md) | [(0.6) d](/filings/0001140361-26-006550.md) | [0.4](/filings/0001140361-26-020544.md) | [0.5](/filings/0001140361-26-032236.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001140361-24-046229.md) | [0.0 d](/filings/0001140361-25-006103.md) | [0.2](/filings/0001140361-25-018382.md) | [0.0](/filings/0001140361-25-030265.md) | [(0.1)](/filings/0001140361-25-041386.md) | [0.1 d](/filings/0001140361-26-006550.md) | [4.2](/filings/0001140361-26-020544.md) | [0.0](/filings/0001140361-26-032236.md) | [(0.5)](/filings/0001140361-25-041386.md) | [(0.2) d](/filings/0001140361-26-006550.md) | [0.1](/filings/0001140361-26-020544.md) | [0.2](/filings/0001140361-26-032236.md) |
| Net income | $m | [0.6](/filings/0001140361-24-046229.md) | [1.9 d](/filings/0001140361-25-006103.md) | [0.5](/filings/0001140361-25-041386.md) | [0.1](/filings/0001140361-25-041386.md) | [(0.1)](/filings/0001140361-25-041386.md) | [0.3 d](/filings/0001140361-26-006550.md) | [11.4](/filings/0001140361-26-032236.md) | [(0.2)](/filings/0001140361-26-032236.md) | [(1.4)](/filings/0001140361-25-041386.md) | [(0.9) d](/filings/0001140361-26-006550.md) | [0.2](/filings/0001140361-26-032236.md) | [0.4](/filings/0001140361-26-032236.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001140361-24-046229.md) | not reported | [0.06](/filings/0001140361-25-018382.md) | [0.01](/filings/0001140361-25-030265.md) | [(0.02)](/filings/0001140361-25-041386.md) | not reported | [1.35](/filings/0001140361-26-020544.md) | [(0.02)](/filings/0001140361-26-032236.md) | [(0.17)](/filings/0001140361-25-041386.md) | not reported | [0.03](/filings/0001140361-26-020544.md) | [0.05](/filings/0001140361-26-032236.md) |
| Basic EPS | $ per share | [0.08](/filings/0001140361-24-046229.md) | not reported | [0.06](/filings/0001140361-25-018382.md) | [0.01](/filings/0001140361-25-030265.md) | [(0.02)](/filings/0001140361-25-041386.md) | not reported | [1.36](/filings/0001140361-26-020544.md) | [(0.02)](/filings/0001140361-26-032236.md) | [(0.17)](/filings/0001140361-25-041386.md) | not reported | [0.03](/filings/0001140361-26-020544.md) | [0.05](/filings/0001140361-26-032236.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.6](/filings/0001140361-23-052092.md) | [12.2](/filings/0001140361-25-006103.md) | [12.3](/filings/0001140361-24-025440.md) | [11.5](/filings/0001140361-24-036240.md) | [10.1](/filings/0001140361-24-046229.md) | [13.3](/filings/0001140361-26-006550.md) | [23.6](/filings/0001140361-25-018382.md) | [16.4](/filings/0001140361-25-030265.md) | [12.0](/filings/0001140361-25-041386.md) | [16.1](/filings/0001140361-26-032236.md) | [10.1](/filings/0001140361-26-020544.md) | [6.4](/filings/0001140361-26-032236.md) |
| Current assets | $m | [48.2](/filings/0001140361-23-052092.md) | [51.3](/filings/0001140361-25-006103.md) | [50.2](/filings/0001140361-24-025440.md) | [50.8](/filings/0001140361-24-036240.md) | [50.4](/filings/0001140361-24-046229.md) | [50.5](/filings/0001140361-26-006550.md) | [59.4](/filings/0001140361-25-018382.md) | [54.5](/filings/0001140361-25-030265.md) | [49.7](/filings/0001140361-25-041386.md) | [50.6](/filings/0001140361-26-032236.md) | [44.9](/filings/0001140361-26-020544.md) | [44.5](/filings/0001140361-26-032236.md) |
| Total assets | $m | [68.7](/filings/0001140361-23-052092.md) | [72.1](/filings/0001140361-25-006103.md) | [72.4](/filings/0001140361-24-025440.md) | [72.8](/filings/0001140361-24-036240.md) | [73.0](/filings/0001140361-24-046229.md) | [74.9](/filings/0001140361-26-006550.md) | [77.9](/filings/0001140361-25-018382.md) | [76.5](/filings/0001140361-25-030265.md) | [84.5](/filings/0001140361-25-041386.md) | [86.6](/filings/0001140361-26-032236.md) | [81.5](/filings/0001140361-26-020544.md) | [81.6](/filings/0001140361-26-032236.md) |
| Current liabilities | $m | [7.6](/filings/0001140361-23-052092.md) | [8.9](/filings/0001140361-25-006103.md) | [7.8](/filings/0001140361-24-025440.md) | [7.9](/filings/0001140361-24-036240.md) | [7.9](/filings/0001140361-24-046229.md) | [9.9](/filings/0001140361-26-006550.md) | [13.2](/filings/0001140361-25-018382.md) | [11.1](/filings/0001140361-25-030265.md) | [9.5](/filings/0001140361-25-041386.md) | [9.8](/filings/0001140361-26-032236.md) | [10.6](/filings/0001140361-26-020544.md) | [9.8](/filings/0001140361-26-032236.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [53.6](/filings/0001140361-24-046229.md) | [56.3](/filings/0001140361-26-006550.md) | [57.2](/filings/0001140361-25-041386.md) | [57.5](/filings/0001140361-25-041386.md) | [57.6](/filings/0001140361-25-041386.md) | [57.2](/filings/0001140361-26-032236.md) | [55.6](/filings/0001140361-26-032236.md) | [55.9](/filings/0001140361-26-032236.md) | [53.4](/filings/0001140361-25-041386.md) | [52.6](/filings/0001140361-26-032236.md) | [46.5](/filings/0001140361-26-032236.md) | [47.0](/filings/0001140361-26-032236.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.1) d](/filings/0001140361-24-046229.md) | [3.3 d](/filings/0001140361-25-006103.md) | [1.1](/filings/0001140361-25-018382.md) | [(0.5) d](/filings/0001140361-25-030265.md) | [(0.5) d](/filings/0001140361-25-041386.md) | [4.5 d](/filings/0001140361-26-006550.md) | [(0.5)](/filings/0001140361-26-020544.md) | [(3.6) d](/filings/0001140361-26-032236.md) | [(1.4) d](/filings/0001140361-25-041386.md) | [5.0 d](/filings/0001140361-26-006550.md) | [0.9](/filings/0001140361-26-020544.md) | [(3.3) d](/filings/0001140361-26-032236.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001140361-24-046229.md) | [0.2 d](/filings/0001140361-25-006103.md) | [1.2](/filings/0001140361-25-018382.md) | [0.2 d](/filings/0001140361-25-030265.md) | [0.9 d](/filings/0001140361-25-041386.md) | [0.7 d](/filings/0001140361-26-006550.md) | [1.3](/filings/0001140361-26-020544.md) | [3.7 d](/filings/0001140361-26-032236.md) | [1.6 d](/filings/0001140361-25-041386.md) | [0.9 d](/filings/0001140361-26-006550.md) | [0.6](/filings/0001140361-26-020544.md) | [0.4 d](/filings/0001140361-26-032236.md) |
| Dividends paid | $m | not reported | not reported | [0.0](/filings/0001140361-25-018382.md) | [0.0 d](/filings/0001140361-25-030265.md) | [0.0 d](/filings/0001140361-25-041386.md) | [0.0 d](/filings/0001140361-26-006550.md) | [12.7](/filings/0001140361-26-020544.md) | [0.0 d](/filings/0001140361-26-032236.md) | [0.0 d](/filings/0001140361-25-041386.md) | [0.0 d](/filings/0001140361-26-006550.md) | [6.1](/filings/0001140361-26-020544.md) | [0.0 d](/filings/0001140361-26-032236.md) |
| Share repurchases | $m | [0.0 d](/filings/0001140361-24-046229.md) | [0.0 d](/filings/0001140361-25-006103.md) | not reported | not reported | [0.0 d](/filings/0001140361-25-041386.md) | [0.0 d](/filings/0001140361-26-006550.md) | not reported | not reported | [1.3 d](/filings/0001140361-25-041386.md) | [(0.1) d](/filings/0001140361-26-006550.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,273](/filings/0001140361-23-052092.md) | [8,350](/filings/0001140361-24-025440.md) | [8,367](/filings/0001140361-24-036240.md) | [8,405](/filings/0001140361-24-046229.md) | [8,500](/filings/0001140361-25-018382.md) | [8,505](/filings/0001140361-25-030265.md) | [8,423](/filings/0001140361-25-041386.md) | [8,595](/filings/0001140361-26-020544.md) | [8,495](/filings/0001140361-26-032236.md) | [8,142](/filings/0001140361-25-041386.md) | [8,103](/filings/0001140361-26-020544.md) | [8,155](/filings/0001140361-26-032236.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,192,075 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001140361-26-032236.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.